EHABHIGH SIGNALFINANCIAL10-K

EHAB demonstrated a dramatic turnaround from substantial losses to near breakeven while strengthening its balance sheet and expanding operations.

The company's ability to nearly eliminate losses while generating stronger operating cash flows suggests successful operational improvements and cost management initiatives. This represents a meaningful inflection point for a healthcare services company that had been struggling with profitability, though investors should monitor whether this improvement can be sustained.

Comparing 2026-03-05 vs 2025-03-06View on EDGAR →
FINANCIAL ANALYSIS

EHAB showed substantial financial improvement with losses declining dramatically from the prior year while operating cash flow grew meaningfully to $70.7M. The balance sheet strengthened considerably with cash increasing over 50% to $43.6M and total debt reduced by 13.5%, demonstrating improved liquidity and deleveraging. The overall picture signals a company successfully executing a turnaround strategy with both operational performance and financial position moving in positive directions.

FINANCIAL STATEMENT CHANGES
Net Income
P&L
+97.1%
-$156.2M-$4.6M

Net income grew 97.1% — bottom-line growth signals improving overall business health.

Cash & Equivalents
Balance Sheet
+53.5%
$28.4M$43.6M

Cash position surged 53.5% — strong cash generation or capital raise providing significant financial cushion.

Operating Cash Flow
Cash Flow
+38.1%
$51.2M$70.7M

Operating cash flow surged 38.1% — exceptional cash generation, highest quality earnings signal.

Capital Expenditure
Cash Flow
+28.9%
$3.8M$4.9M

Capex increased 28.9% — ongoing investment in capacity or infrastructure for future growth.

Total Debt
Balance Sheet
-13.5%
$492.6M$426.0M

Debt reduced 13.5% — deleveraging strengthens balance sheet and reduces financial risk.

Total Liabilities
Balance Sheet
-10.3%
$672.1M$603.0M

Liabilities reduced 10.3% — deleveraging improves balance sheet strength and financial flexibility.

LANGUAGE CHANGES
NEW — 2026-03-05
PRIOR — 2025-03-06
ADDED
The registrant had outstanding 50,723,245 shares of common stock as of February 26, 2026.
We strive to provide our patients with superior clinical care, where our patients prefer it: in their homes.
For over 25 years, we have provided care in the low-cost home setting while achieving high-quality clinical outcomes and demonstrating a consistent ability to innovate during varying economic and regulatory climates.
As of December 31, 2025, we operated 249 home health and 117 hospice locations across 34 states.
Each provides a comprehensive range of high quality, Medicare-certified services.
+7 more — sign up free →
REMOVED
The registrant had outstanding 50,479,951 shares of common stock as of March 3, 2025.
We strive to provide superior, cost-effective care where patients prefer it: in their homes.
For over twenty-five years, we have provided care in the low cost home setting while achieving high-quality clinical outcomes.
As of December 31, 2024, our footprint comprised 255 home health and 115 hospice locations across 34 states.
population, an increased focus on shifting care to lower-cost settings, and patients preference for home-based care.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →